Primecap Management’s Adverum Biotechnologies ADVM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-45,500
| Closed | -$2.48M | – | 293 |
|
|
2019
Q3 | $2.48M | Sell |
45,500
-62,700
| -58% | -$3.42M | ﹤0.01% | 267 |
|
|
2019
Q2 | $12.9M | Buy |
108,200
+3,000
| +3% | +$357K | 0.01% | 235 |
|
|
2019
Q1 | $5.51M | Hold |
105,200
| – | – | ﹤0.01% | 253 |
|
|
2018
Q4 | $3.31M | Buy |
105,200
+21,690
| +26% | +$683K | ﹤0.01% | 261 |
|
|
2018
Q3 | $5.05M | Buy |
83,510
+33,170
| +66% | +$2.01M | ﹤0.01% | 261 |
|
|
2018
Q2 | $2.67M | Hold |
50,340
| – | – | ﹤0.01% | 268 |
|
|
2018
Q1 | $2.92M | Hold |
50,340
| – | – | ﹤0.01% | 261 |
|
|
2017
Q4 | $1.76M | Buy |
50,340
+1,890
| +4% | +$66.2K | ﹤0.01% | 271 |
|
|
2017
Q3 | $1.77M | Sell |
48,450
-620
| -1% | -$22.6K | ﹤0.01% | 265 |
|
|
2017
Q2 | $1.23M | Buy |
49,070
+5,030
| +11% | +$126K | ﹤0.01% | 277 |
|
|
2017
Q1 | $1.19M | Buy |
44,040
+1,480
| +3% | +$40K | ﹤0.01% | 271 |
|
|
2016
Q4 | $1.23M | Sell |
42,560
-70
| -0.2% | -$2.03K | ﹤0.01% | 268 |
|
|
2016
Q3 | $1.75M | Buy |
42,630
+240
| +0.6% | +$9.86K | ﹤0.01% | 262 |
|
|
2016
Q2 | $1.34M | Sell |
42,390
-310
| -0.7% | -$9.8K | ﹤0.01% | 263 |
|
|
2016
Q1 | $2.21M | Buy |
42,700
+4,920
| +13% | +$254K | ﹤0.01% | 255 |
|
|
2015
Q4 | $3.6M | Buy |
37,780
+540
| +1% | +$51.4K | ﹤0.01% | 247 |
|
|
2015
Q3 | $3.07M | Buy |
37,240
+30,410
| +445% | +$2.51M | ﹤0.01% | 254 |
|
|
2015
Q2 | $1.11M | Buy |
6,830
+4,900
| +254% | +$796K | ﹤0.01% | 255 |
|
|
2015
Q1 | $782K | Sell |
1,930
-1,870
| -49% | -$758K | ﹤0.01% | 253 |
|
|
2014
Q4 | $2.05M | Sell |
3,800
-790
| -17% | -$427K | ﹤0.01% | 245 |
|
|
2014
Q3 | $1.57M | Buy |
+4,590
| New | +$1.57M | ﹤0.01% | 246 |
|